Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
September 18, 2025 Off

Novo Nordisk’s oral semaglutide 25 mg (Wegovy® in a pill*) delivered 16.6% weight loss in people with obesity in a newly published study

By GlobeNewswire

Oral semaglutide 25 mg (the once-daily pill formulation of Wegovy®) achieved significant weight loss, with one in three study participants…

September 18, 2025 Off

Eagle Pharmaceuticals Announces Availability of Proxy Materials and Audited Financial Statements for the 2023 and 2024 Fiscal Years

By GlobeNewswire

WOODCLIFF LAKE, N.J., Sept. 17, 2025 (GLOBE NEWSWIRE) — Eagle Pharmaceuticals, Inc. (OTCMKTS: EGRX) (the “Company” or “Eagle”) today announced…

September 18, 2025 Off

Arvinas Provides Update on Collaboration with Pfizer and Announces Further Actions to Support Value Creation

By GlobeNewswire

Arvinas and Pfizer plan to jointly select third party for the out-licensing and commercialization of vepdegestrant Additional cost optimization measures…

September 18, 2025 Off

Biogen Receives European Commission Approval for ZURZUVAE® (zuranolone), the First and Only Treatment Approved for Women with Postpartum Depression in Europe

By GlobeNewswire

Postpartum depression is a leading cause of maternal mortality in Europe1-2, and is one of the most common medical conditions…

September 18, 2025 Off

Vor Bio Announces Oral Presentation of 48-Week China Phase 3 Generalized Myasthenia Gravis Clinical Study at AANEM

By GlobeNewswire

CAMBRIDGE, Mass., Sept. 17, 2025 (GLOBE NEWSWIRE) — Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of…

September 18, 2025 Off

NANOBIOTIX Announces New Results From a Phase 1 Study Evaluating JNJ-1900 (NBTXR3) in Combination With Immune Checkpoint Inhibitors as a 2L+ Therapy for Patients With Primary Cutaneous Melanoma Resistant to Anti-PD-1

By GlobeNewswire

Data show a favorable safety profile and early efficacy signals in a heavily pre-treated population whose cancer progressed after multiple…

September 18, 2025 Off

Vaxart Appoints W. Mark Watson as Lead Independent Director

By GlobeNewswire

In process of adopting a Director stock ownership policy to reinforce commitment of aligning the Board’s interests with stockholders Vaxart encourages…

September 18, 2025 Off

Rezolute Reports Fourth Quarter and Full Year Fiscal 2025 Financial Results and Provides Business Update

By GlobeNewswire

REDWOOD CITY, Calif., Sept. 17, 2025 (GLOBE NEWSWIRE) — Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage rare…

September 18, 2025 Off

Thirty Inspiring Middle School Scientists and Engineers Shine as Finalists in the Thermo Fisher Scientific Junior Innovators Challenge

By GlobeNewswire

Representing 10 U.S. states and Puerto Rico, finalists will compete in Washington, D.C., for more than $100,000 in awards Meet…

September 18, 2025 Off

Mapi Pharma Announces First Patient Recruited in Phase-I/II Study of Cariprazine Depot Once Monthly Injection

By GlobeNewswire

NESS ZIONA, Israel, Sept. 17, 2025 (GLOBE NEWSWIRE) — Mapi Pharma Ltd., a fully integrated, late-stage clinical development biopharmaceutical company…

Posts pagination

Previous 1 … 83 84 85 … 3,605 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine